Memantine

Products Memantine is commercially available as film-coated tablets, meltable tablets, and oral solution (Axura, Ebixa). It has been approved in many countries since 2003. Generic versions were registered in 2014. Structure and properties Memantine (C12H21N, Mr = 179.3 g/mol) is present in drugs as memantine hydrochloride, a white powder that is insoluble in water. Memantine … Memantine

Propiverine

Products Propiverine was approved in many countries in 2020 in the form of modified-release hard capsules (Mictonorm). Later, coated tablets were also registered (Mictonet). This is an older active ingredient that was available earlier in Germany, for example. Structure and properties Propiverine (C23H29NO3, Mr = 367.5 g/mol) is present in drugs as propiverine hydrochloride. Active … Propiverine

Amantadine

Products Amantadine is commercially available as film-coated tablets, capsules, and an infusion solution (Symmetrel, PK-Merz). It has been approved in many countries since 1966. Structure and properties Amantadine (C10H17N, Mr = 151.2 g/mol) is present in drugs as amantadine sulfate or amantadine hydrochloride. Amantadine hydrochloride is a white crystalline powder that is readily soluble in … Amantadine

Trimethoprim and Sulfamethoxazole

Products Trimethoprim and sulfamethoxazole are commercially available in tablet and syrup form (Bactrim, generics). The drug has been approved in many countries since 1969. The Bactrim syrup is no longer available, but a generic is available (Nopil syrup). The fixed combination of the two active ingredients is also called cotrimoxazole. Structure and properties Trimethoprim (C14H18N4O3, … Trimethoprim and Sulfamethoxazole

Antiparkinsonian

Effects The majority of antiparkinsonian drugs are directly or indirectly dopaminergic. Some are anticholinergic in action. Indications Parkinson’s disease, including drug-induced Parkinson’s disease in some cases. Drug treatment Overview of drug therapy: 1. dopaminergic agents Levodopa is a precursor of dopamine and is considered the most important and effective pharmacotherapy for PD. Combining it with … Antiparkinsonian

Triflupromazine: Effects, Uses & Risks

Triflupromazine belongs to the class of neuroleptics. As such, the drug is used to treat psychiatric disorders. In addition, however, it can also be used in other medical specialties. In the Federal Republic of Germany, triflupromazine may no longer be used or prescribed since 2003 due to changes in drug law, as there is no … Triflupromazine: Effects, Uses & Risks

Swine Flu (Influenza A/H1N1/2009)

Symptoms Flu symptoms with sudden onset: Fever, chills Muscle, joint and headache Weakness, fatigue Sore throat Dry irritating cough Especially in young children also digestive problems such as nausea, vomiting and diarrhea Other complaints (see flu) Complications The course is usually benign, mild to moderate, and self-limiting. Rarely, however, a severe and life-threatening course is … Swine Flu (Influenza A/H1N1/2009)

Flu Causes and Treatment

Symptoms Influenza (flu) usually begins suddenly and manifests itself in the following symptoms: High fever, chills, sweating. Muscle, limb and headache Weakness, fatigue, feeling sick. Cough, usually a dry irritating cough Rhinitis, nasal congestion, sore throat Digestive disorders such as nausea, vomiting and diarrhea, mainly in children. The flu occurs mainly in the winter months. … Flu Causes and Treatment

Ropinirole: Effects, Uses & Risks

The drug ropinirole belongs to the dopamine agonists. It is used to treat Parkinson’s disease and restless legs syndrome. What is ropinirole? The drug ropinirole belongs to the group of dopamine agonists. It is used to treat Parkinson’s disease and restless legs syndrome. Ropinirole is a medicinal substance that belongs to the group of dopamine … Ropinirole: Effects, Uses & Risks

Pramipexole

Products Pramipexole is commercially available in tablet and sustained-release tablet form (Sifrol, Sifrol ER, generics). It has been approved in many countries since 1997; generics were released in 2010 and entered the market in January 2011. Sifrol ER sustained-release tablets were relaunched by the original manufacturer in 2010. Structure and properties Pramipexole (C10H17N3S, Mr = … Pramipexole

Flavoxat

Products Flavoxate is commercially available in the form of film-coated tablets (Urispas). It has been approved in many countries since 2008. Structure and properties Flavoxate (C24H25NO4, Mr = 391.5 g/mol) is present in drugs as flavoxate hydrochloride, an oxo-benzopyran and piperidine derivative. An active metabolite is involved in the effects. Effects Flavoxate (ATC G04BD02) has … Flavoxat